AKT Kinase Inhibitor manufacturers
- AKT Kinase Inhibitor
-
- $138.00 / 1mg
-
2026-03-04
- CAS:842148-40-7
- Min. Order:
- Purity: 98.30%
- Supply Ability: 10g
- AKT Kinase Inhibitor
-
- $138.00 / 1mg
-
2026-03-04
- CAS:842148-40-7
- Min. Order:
- Purity: 98.30%
- Supply Ability: 10g
- AKT Kinase Inhibitor
-
- $2.00 / 25KG
-
2025-10-13
- CAS:842148-40-7
- Min. Order: 1KG
- Purity: 99%
- Supply Ability: g-kg-ton
|
| | AKT Kinase Inhibitor Basic information |
| Product Name: | AKT Kinase Inhibitor | | Synonyms: | AKT Kinase Inhibitor;3-[2-(4-Amino-1,2,5-oxadiazol-3-yl)-7-(3-aminopropoxy)-1-ethyl-1H-imidazo[4,5-c]pyridin-4-yl]-2-propyn-1-ol;2-Propyn-1-ol, 3-[2-(4-aMino-1,2,5-oxadiazol-3-yl)-7-(3-aMinopropoxy)-1-ethyl-1H-iMidazo[4,5-c]pyridin-4-yl]-;AKT Kinase Inhibitor
(2-Propyn-1-ol, 3-[2-(4-amino-1,2,5-oxadiazol-3-yl)-7-(3-aminopropoxy)-1-ethyl-1H-imidazo[4,5-c]pyridin-4-yl]-);3-[2-(4-amino-1;5-c]pyridin-4-yl]-;5-oxadiazol-3-yl)-7-(3-aminopropoxy)-1-ethyl-1H-imidazo[4;AKT Kinase Inhibitor USP/EP/BP | | CAS: | 842148-40-7 | | MF: | C16H19N7O3 | | MW: | 357.37 | | EINECS: | | | Product Categories: | | | Mol File: | 842148-40-7.mol |  |
| | AKT Kinase Inhibitor Chemical Properties |
| Boiling point | 678.8±65.0 °C(Predicted) | | density | 1.50 | | storage temp. | Store at -20°C | | solubility | DMSO : 16.67 mg/mL (46.65 mM; Need ultrasonic)H2O : < 0.1 mg/mL (insoluble) | | form | Powder | | pka | 12.98±0.10(Predicted) | | color | White to light yellow |
| | AKT Kinase Inhibitor Usage And Synthesis |
| Uses | AKT Kinase Inhibitor is an Akt kinase inhibitor with anti-tumor activity[1]. | | Biological Activity | AKT Kinase Inhibitor is an Akt inhibitor with antitumor activity. | | in vivo | Trop-2 expressing tumors subcutaneously injected in animal models show a striking reduction of growth following treatment with specific drugs that inhibit Akt activity. Therefore Akt has a central functional role in mediating the Trop-2-dependent growth stimulus. | | target | | | References | [1] Saverio Alberti, et al. Use of trop-2 as predictive marker of response to anti-tumor therapy based on inhibitors of cd9, akt and molecules of the tetraspanin signalling network. WO2013171777A2. |
| | AKT Kinase Inhibitor Preparation Products And Raw materials |
|